翰宇药业：拟发行A股股票

Core Viewpoint - The company announced the approval of a plan to issue A-shares to specific investors during a board meeting scheduled for September 25, 2025, pending regulatory approvals [1] Group 1 - The company will hold a board and supervisory board meeting on September 25, 2025, to review the proposal for the issuance of A-shares [1] - The relevant proposal and announcement have been disclosed on the Giant Tide Information Network [1] - The issuance of shares is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission [1]